{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:04:22Z","timestamp":1784930662002,"version":"3.55.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.heliyon.2023.e19968","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T04:42:47Z","timestamp":1694234567000},"page":"e19968","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Outpatient parenteral antibiotic therapy (OPAT) for the management of bronchiectasis"],"prefix":"10.1016","volume":"9","author":[{"given":"Jacky","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Al Harasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1801-450X","authenticated-orcid":false,"given":"Michael","family":"Pallin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e19968_bib1","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1136\/bmj.319.7224.1547","article-title":"Economic evaluation of hospital at home versus hospital care: cost minimisation analysis of data from randomised controlled trial","volume":"319","author":"Jones","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.heliyon.2023.e19968_bib2","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.ijnurstu.2013.03.006","article-title":"Patient preference and satisfaction in hospital-at-home and usual hospital care for COPD exacerbations: results of a randomised controlled trial","volume":"50","author":"Utens","year":"2013","journal-title":"Int. J. Nurs. Stud."},{"key":"10.1016\/j.heliyon.2023.e19968_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/tsaco-2020-000481","article-title":"eClinic: increasing use of telehealth as a risk reduction strategy during the covid-19 pandemic","volume":"5","author":"Kemp","year":"2020","journal-title":"Trauma Surg Acute Care Open"},{"key":"10.1016\/j.heliyon.2023.e19968_bib4","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Clinical Practice Guidelines for Pulmonary Therapies C. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"Flume","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.heliyon.2023.e19968_bib5","first-page":"CD001917","article-title":"Home versus hospital intravenous antibiotic therapy for cystic fibrosis","author":"Balaguer","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.heliyon.2023.e19968_bib6","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1136\/archdischild-2016-311535.71","article-title":"Service evaluation of a cystic fibrosis home intravenous antibiotic service provided by a nhs foundation trust","volume":"101","author":"Elsey","year":"2016","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.heliyon.2023.e19968_bib7","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jcf.2021.11.009","article-title":"Association of site of treatment with clinical outcomes following intravenous antimicrobial treatment of a pulmonary exacerbation","volume":"21","author":"Sanders","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.heliyon.2023.e19968_bib8","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jcf.2021.02.012","article-title":"The effect of oral and intravenous antimicrobials on pulmonary exacerbation recovery in cystic fibrosis","volume":"20","author":"VanDevanter","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.heliyon.2023.e19968_bib9","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1164\/rccm.201203-0487OC","article-title":"Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis","volume":"186","author":"Chalmers","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.heliyon.2023.e19968_bib10","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000501085","article-title":"Outpatient parenteral antimicrobial treatment for non-cystic fibrosis bronchiectasis exacerbations: a prospective multicentre observational cohort study","volume":"98","author":"Lopez-Cortes","year":"2019","journal-title":"Respiration"},{"key":"10.1016\/j.heliyon.2023.e19968_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/npjpcrm.2014.90","article-title":"A prospective cohort study of the use of domiciliary intravenous antibiotics in bronchiectasis","volume":"24","author":"Bedi","year":"2014","journal-title":"NPJ Prim Care Respir Med"},{"key":"10.1016\/j.heliyon.2023.e19968_bib12","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/ppul.24670","article-title":"Is out-patient based treatment of bronchiectasis exacerbations in children comparable to inpatient based treatment?","volume":"55","author":"O'Rourke","year":"2020","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.heliyon.2023.e19968_bib13","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/imj.15213","article-title":"Observational study of the incidence and factors associated with patient readmission from home-based care under the Hospital in the Home programme","volume":"51","author":"Lim","year":"2021","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.heliyon.2023.e19968_bib14","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00051-2017","article-title":"Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research","volume":"49","author":"Hill","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.heliyon.2023.e19968_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.14740\/jocmr3757","article-title":"Peripheral inserted central catheter use and related infections in clinical practice: a literature update","volume":"11","author":"Velissaris","year":"2019","journal-title":"J. Clin. Med. Res."},{"key":"10.1016\/j.heliyon.2023.e19968_bib16","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1183\/09031936.97.10040896","article-title":"Home intravenous therapy in cystic fibrosis: a prospective randomized trial examining clinical, quality of life and cost aspects","volume":"10","author":"Wolter","year":"1997","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.heliyon.2023.e19968_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049733","article-title":"Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses","volume":"11","author":"Dimitrova","year":"2021","journal-title":"BMJ Open"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023071761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023071761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T21:23:30Z","timestamp":1784928210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023071761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2405844023071761"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19968","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outpatient parenteral antibiotic therapy (OPAT) for the management of bronchiectasis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19968","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e19968"}}